Px Pulse
Claim This Podcastby Px Pulse
Podcast Authority
Beta
Podcast Overview
<p>Px Pulse explores vital topics confronting the field of HIV prevention research. Our monthly podcast will deepen your knowledge and help you “check the pulse” of this fast-paced field and the urgent challenges still ahead. Tune in for interviews, first-person accounts and robust discussion from advocates, researchers, policy-makers and community stakeholders as they take on critical issues facing HIV prevention research today.</p>
Language
🇺🇲
Publishing Since
10/27/2017
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
BetaRecommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Px Pulse
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
August 15, 2025
S5 Ep19: Up Next: A monthly pill for PrEP?
<div>The drug maker <a href="https://www.merck.com/news/merck-to-initiate-phase-3-trials-for-investigational-once-monthly-hiv-prevention-pill/">Merck recently announced</a> its plans to start two new trials, known as the EXPrESSIVE program, testing a monthly pill for PrEP. A once-a-month PrEP pill holds great potential for the field. Even with daily pills, a monthly ring, or long acting injectables such as <a href="https://www.prepwatch.org/products/injectable-cab-for-prep/">cabotegravir</a> and recently FDA-approved lenacapavir, there’ll be people who can’t find what they really need for prevention. <br> <br> For advocates who follow prevention, there’s a lot to know about these trials, and powerful lessons to learn about <a href="https://www.avac.org/gpp">Good Participatory Practice (GPP)</a> and impactful involvement of stakeholders—especially community—in research. GPP has been a cornerstone of the process of design and protocol development for the EXPrESSIVE trials, and it doesn’t stop there. <br> <br> This episode features <a href="https://www.merck.com/stories/meet-two-scientists-at-the-forefront-of-our-hiv-research/">Merck Senior Principal Scientist Rebeca Plank</a> and AVAC’s Regional Manager for Research Engagement Grace Kumwenda. They explain why a monthly pill could be so important to HIV prevention and how GPP is shaping the design and rollout of the trials. <br> <br> </div>
May 13, 2025
S5 Ep18: Critical Advocacy: How Civil Society is defending the HIV Response and Global Health
<div>The upending of US policy by the new presidential administration has collapsed the foundation for global health and the HIV response at every level, from research to program delivery. It’s been a desperate scramble for everyone who cares the lives and wellbeing of those impacted by HIV. Wading into the chaos, all over the world are advocates who began organizing within days, even minutes—as soon as the US government federal executive orders started coming down. <br> <br> Positive change depends on fierce and effective community leadership, and pressuring powerbrokers to do the right thing.) <br> <br> Two veteran global health leaders from civil society talk about how civil society is responding. Amanda Banda is Strategic Advisor to the <a href="https://avac.org/project/compass/">COMPASS Coalition</a> and Asia Russell is Executive Director of<a href="https://healthgap.org/author/asia/"> Health Gap</a>, and both are members of CHANGE, a coalition with more than 1,500 people, from organizations in nearly every continent, working in coordination to defend global health and the HIV response.<br> <a href="https://avac.org/resource/critical-advocacy/">https://avac.org/resource/critical-advocacy/</a><br> Key Resources</div> <ul> <li>Join weekly CHANGE calls, every Thursday 9 AM Washington DC | 4 PM Nairobi to get involved, send us an email for the link to join: <a href="mailto:contact.change.2025@gmail.com"><strong>contact.change.2025@gmail.com</strong></a> </li> <li>CHANGE resources to fight back against US government HIV and global health cuts and funding freezes, visit <a href="https://pepfarwatch.org/pepfar-funding-freeze"><strong><a href="http://pepfarwatch.org/pepfar-funding-freeze">pepfarwatch.org/pepfar-funding-freeze</a></strong></a> </li> <li> <a href="https://avac.org/search/?_search=Research+matter"><strong>Research Matters – Resources to Protect Research Funding</strong></a> </li> <li><a href="https://avac.org/resource/report/pxwire-volume15-issue2/"><strong>PxWire: May 2025</strong></a></li> <li> <a href="https://avac.org/blog/data-trackers/"><strong>Despite USG Global Health Collapse, Here Are Several Data Trackers To Support Your Advocacy</strong></a> </li> </ul>
April 7, 2025
S5 Ep17: Lawsuit Wins and What’s at Stake
<div>On February 10, AVAC and the Journalism Development Network came forward with <a href="https://www.citizen.org/"><strong>Public Citizen</strong></a> to sue the new US presidential administration, seeking emergency relief from the funding freeze on all foreign assistance. We know the impact of the withdrawal of funds has been devastating. AVAC’s lawsuit is one of several efforts to fight back in the courts.<br> <br> AVAC’s Executive Director, <a href="https://avac.org/mitchell-warren"><strong>Mitchell Warren</strong></a> and Public Citizen Litigator, <a href="https://www.citizen.org/about/person/lauren-bateman/"><strong>Lauren Bateman</strong></a> explain these lawsuits and why they matter. For resources and other background go to <a href="https://avac.org/resource/lawsuit-wins-and-whats-at-stake/">https://avac.org/resource/lawsuit-wins-and-whats-at-stake/</a><br> <br> <br> </div>
51 total episodes available
Deep-dive analytics for Px Pulse
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Px Pulse?
<p>Px Pulse explores vital topics confronting the field of HIV prevention research. Our monthly podcast will deepen your knowledge and help you “check the pulse” of this fast-paced field and the urgent challenges still ahead. Tune in for interviews, first-person accounts and robust discussion from advocates, researchers, policy-makers and community stakeholders as they take on critical issues facing HIV prevention research today.</p> - How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 10 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.